Advantages and Emerging Problems of Novel Treatments for Transthyretin Cardiac Amyloidosis

Circ J. 2019 Dec 25;84(1):9-10. doi: 10.1253/circj.CJ-19-1044. Epub 2019 Dec 6.

Authors

Takahiro Okumura¹, Toyoaki Murohara¹

Affiliation

¹ Department of Cardiology, Nagoya University Graduate School of Medicine.

PMID: 31813898
DOI: 10.1253/circj.CJ-19-1044

No abstract available

Publication types

Comment

MeSH terms

Amyloid Neuropathies, Familial*
Benzoxazoles
Humans
Prealbumin*

Substances

Benzoxazoles
Prealbumin
tafamidis